Search

Arthur Roman Mlodozeniec

from San Francisco, CA
Age ~87
Get Report
Also known as:
Arthur R Mlodozeniec, Arthur C
Phone and address:
466 Staples Ave, San Francisco, CA 94112
Related to:
Gary MlodozeniecJean L PetersonSheila E Huigens, 76Wendy J Huigens, 51Tracey L Mccormick, 55John H PetersonDianne J Peterson, 80Tracey L Mlodozeniec, 55Michael T Huigens, 54
Connected to:
Bogdan Mlodzik, 77Maryanne M Mlodzik, 69Stanley Mlostek, 65Ashley N Mlot, 27Heather Mlot, 70Alan J Mlotkowski, 29Brent A Mlott, 59Jack L Mlsna, 61Natalie I Mlsna, 60Paul E Mlsna, 55

Arthur Mlodozeniec Phones & Addresses

  • 466 Staples Ave, San Francisco, CA 94112
  • 652 Sand Hill Rd, Menlo Park, CA 94025 (650) 854-1830
  • Santa Clara, CA
  • Lawrence, KS
  • Boston, NY
  • Mountain View, CA
  • Lexington, KY
  • San Jose, CA
  • Newry, ME

Industries

Biotechnology

Resumes

Resumes

Arthur Mlodozeniec Photo 1

Arthur Mlodozeniec

View page
Location:
San Francisco Bay Area
Industry:
Biotechnology

Business Records

Name / Title
Company / Classification
Phones & Addresses
Arthur Mlodozeniec
CTO
CONFORMIA SOFTWARE, INC
Software Publishers
1001 Marshall St, Redwood City, CA 94063
(650) 780-5850
Arthur Mlodozeniec
President
TECHNIPHARM CONSULTING GROUP
652 Sand Hl Cir, Menlo Park, CA 94025
Arthur Mlodozeniec
Vice-President
Pharmquest Corporation
Prepackaged Software Services Telephone Communications · Wired Telecommunications Carriers
82 Pioneer Way, Mountain View, CA 94041
(650) 210-3960

Publications

Us Patents

Drug Delivery System Utilizing Thermosetting Gels

View page
US Patent:
44747527, Oct 2, 1984
Filed:
May 16, 1983
Appl. No.:
6/495240
Inventors:
John L. Haslam - Lawrence KS
Takeru Higuchi - Lawrence KS
Arthur R. Mlodozeniec - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31415
A61K 31435
A61K 3119
A61K 3166
A61K 3174
A61K 3170
A61K 31135
A61K 3154
US Classification:
424 78
Abstract:
Present invention provides a unique drug delivery device for delivering drug by injection into a body. The drug delivery system comprises the drug and polymer which is a liquid at room temperature and a semi-solid or gel at the body temperature.

Drug Delivery System Utilizing Thermosetting Gels

View page
US Patent:
44788223, Oct 23, 1984
Filed:
May 16, 1983
Appl. No.:
6/495239
Inventors:
John L. Haslam - Lawrence KS
Takeru Higuchi - Lawrence KS
Arthur R. Mlodozeniec - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3174
A61K 3170
A61K 31135
A61K 3154
A61K 31415
A61K 31435
A61K 3119
A61K 3166
US Classification:
424 78
Abstract:
This invention relates to a unique drug delivery system for delivering drugs to a body cavity. The drug delivery system comprises a medicament and a polymer such that the drug delivery system is a liquid at room temperature but forms a semi-solid or gel at the body temperature in the body cavity.

Topical Drug Delivery System Utilizing Thermosetting Gels

View page
US Patent:
44747535, Oct 2, 1984
Filed:
May 16, 1983
Appl. No.:
6/495321
Inventors:
John L. Haslam - Lawrence KS
Takeru Higuchi - Lawrence KS
Arthur R. Mlodozeniec - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3174
A61K 3170
A61K 31135
A61K 3154
A61K 31415
A61K 31435
A61K 3119
A61K 3166
US Classification:
424 78
Abstract:
This invention relates to a unique drug delivery system for application to the skin which drug delivery system is a liquid at room temperature, but when administered topically to the skin becomes a semi-solid or gel when warmed by the body.

Ophthalmic Drug Delivery System Utilizing Thermosetting Gels

View page
US Patent:
44747519, Oct 2, 1984
Filed:
May 16, 1983
Appl. No.:
6/495238
Inventors:
John L. Haslam - Lawrence KS
Takeru Higuchi - Lawrence KS
Arthur R. Mlodozeniec - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3174
A61K 3170
A61K 31135
A61K 3154
A61K 31415
A61K 31435
A61K 3119
A61K 3166
US Classification:
424 78
Abstract:
This invention describes the application of selected polymers as novel drug delivery systems which use the body temperature and pH to induce a liquid to gel transition of the polymer which contains a drug or therapeutic agent therein. The goal of such a delivery system is to achieve a greater degree of bioavailability or sustained concentration of a drug.
Control profile
Arthur Roman Mlodozeniec from San Francisco, CA, age ~87 Get Report